(CTRE) CareTrust REIT - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US14174T1079
CTRE: Skilled Nursing Facilities, Seniors Housing, Healthcare Properties
CareTrust REIT, Inc. (NYSE: CTRE) operates as a self-administered, publicly-traded real estate investment trust, specializing in the ownership, acquisition, development, and leasing of healthcare-related properties. Its portfolio primarily includes skilled nursing facilities, seniors housing, and other healthcare assets, strategically located across the United States. The company employs a dual growth strategy, focusing on both external acquisitions and organic expansion through partnerships with quality operators. This approach allows CareTrust REIT to diversify its revenue streams and maintain a robust portfolio of long-term net-leased properties.
From a technical standpoint, CTRE is trading at $28.10 with a 20-day moving average of $28.14, indicating recent price stability. The stocks average true range (ATR) of 0.73 suggests low volatility. Fundamental analysis highlights a market capitalization of $5.265 billion, with a trailing P/E of 35.08 and a forward P/E of 12.97, signaling market expectations for future earnings growth. The price-to-book ratio of 1.86 reflects a premium valuation, while the price-to-sales ratio of 17.77 indicates a growth-oriented investment. With a return on equity of 4.30%, CTREs profitability is moderate but improving.
Over the next three months, CTRE is expected to demonstrate stability with potential for modest growth. The stock may trade in a narrow range near its current price, supported by its strong balance sheet and expanding portfolio. However, the high P/E ratio and low return on equity could lead to investor caution. Positive developments in external growth initiatives or operational efficiencies may drive upward momentum, while any macroeconomic headwinds could limit upside potential.
Additional Sources for CTRE Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CTRE Stock Overview
Market Cap in USD | 5,335m |
Sector | Real Estate |
Industry | REIT - Healthcare Facilities |
GiC Sub-Industry | Health Care REITs |
IPO / Inception | 2014-05-29 |
CTRE Stock Ratings
Growth Rating | 70.7 |
Fundamental | 48.1 |
Dividend Rating | 72.3 |
Rel. Strength | 2.91 |
Analysts | 4.22/5 |
Fair Price Momentum | 31.59 USD |
Fair Price DCF | 27.00 USD |
CTRE Dividends
Dividend Yield 12m | 4.31% |
Yield on Cost 5y | 9.87% |
Annual Growth 5y | 3.01% |
Payout Consistency | 91.1% |
CTRE Growth Ratios
Growth Correlation 3m | 73.3% |
Growth Correlation 12m | 37.8% |
Growth Correlation 5y | 75.9% |
CAGR 5y | 18.93% |
CAGR/Max DD 5y | 0.61 |
Sharpe Ratio 12m | 0.62 |
Alpha | 16.94 |
Beta | 0.076 |
Volatility | 24.83% |
Current Volume | 1812.4k |
Average Volume 20d | 1486.9k |
As of May 02, 2025, the stock is trading at USD 29.07 with a total of 1,812,351 shares traded.
Over the past week, the price has changed by +3.23%, over one month by +2.07%, over three months by +9.94% and over the past year by +21.81%.
Partly, yes. Based on ValueRay Fundamental Analyses, CareTrust REIT (NYSE:CTRE) is currently (May 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 48.13 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CTRE as of May 2025 is 31.59. This means that CTRE is currently overvalued and has a potential downside of 8.67%.
CareTrust REIT has received a consensus analysts rating of 4.22. Therefor, it is recommend to buy CTRE.
- Strong Buy: 6
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 1
According to ValueRays Forecast Model, CTRE CareTrust REIT will be worth about 34.1 in May 2026. The stock is currently trading at 29.07. This means that the stock has a potential upside of +17.37%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 31.7 | 8.9% |
Analysts Target Price | 31.7 | 8.9% |
ValueRay Target Price | 34.1 | 17.4% |